Credit Suisse upgraded AstraZeneca (NYSE: AZN) from Neutral to Outperform.

For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.

Shares of AstraZeneca closed at $34.61 Friday.